13G Filing: Partner Fund Management and Acorda Therapeutics Inc (ACOR)

Page 7 of 13

Page 7 of 13 – SEC Filing

CUSIP No. 00484M106 13G Page 7 of 13 Pages
1.

NAME OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Christopher M. James

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)       ¨

(b)       x

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

U.S. Citizen

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

 

2,765,220 shares

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

See Row 6 above

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

See Row 6 above

10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.9%

12.

TYPE OF REPORTING PERSON

IN

Follow Acorda Therapeutics Inc. (NASDAQ:ACOR)

Page 7 of 13